Biotech · Private company
Stuart Therapeutics, Inc.
Track this companyFree. Adds Stuart Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- ST-100 Ophthalmic SolutionPhase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)PHASE3 · UNKNOWN · started Dec 29, 2023ClinicalTrials.gov NCT06178679 · fetched Nov 12, 2026
- Study of ST-100 as Treatment for Dry Eye DiseasePHASE2 · COMPLETED · started May 17, 2021ClinicalTrials.gov NCT05241470 · fetched Nov 12, 2026